Collaborating with Eddy Yang’s group, a paper is accepted in Nature Cancer, “RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4+ T-cell-dependent antitumor immunity”.
Collaborating with Eddy Yang’s group, a paper is accepted in Nature Cancer, “RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4+ T-cell-dependent antitumor immunity”.